Literature DB >> 30936570

Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?

Anna S Berghoff1,2, Matthias Preusser3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30936570     DOI： 10.1038/s41582-019-0178-0

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.

Authors:  Friedrich Erhart; Matthias Hackl; Hannes Hahne; Johanna Buchroithner; Chen Meng; Simone Klingenbrunner; René Reitermaier; Katrin Fischhuber; Susanna Skalicky; Walter Berger; Sabine Spiegl-Kreinecker; Daniela Lötsch; Gerda Ricken; Bernhard Kuster; Adelheid Wöhrer; Georg Widhalm; Johannes Hainfellner; Thomas Felzmann; Alexander M Dohnal; Christine Marosi; Carmen Visus
Journal:  NPJ Vaccines       Date:  2020-01-16       Impact factor: 7.344

2.  Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.

Authors:  Zhihong Chen; Cameron J Herting; James L Ross; Ben Gabanic; Montse Puigdelloses Vallcorba; Frank Szulzewsky; Megan L Wojciechowicz; Patrick J Cimino; Ravesanker Ezhilarasan; Erik P Sulman; Mingyao Ying; Avi Ma'ayan; Renee D Read; Dolores Hambardzumyan
Journal:  Glia       Date:  2020-07-08       Impact factor: 7.452

Review 3.  The current state of immunotherapy for primary and secondary brain tumors: similarities and differences.

Authors:  Takahide Nejo; Abigail Mende; Hideho Okada
Journal:  Jpn J Clin Oncol       Date:  2020-10-22       Impact factor: 3.019

Review 4.  PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential.

Authors:  Tianrui Yang; Ziren Kong; Wenbin Ma
Journal:  Hum Vaccin Immunother       Date:  2020-07-09       Impact factor: 3.452

Review 5.  Emerging concepts in PD-1 checkpoint biology.

Authors:  Kristen E Pauken; James A Torchia; Apoorvi Chaudhri; Arlene H Sharpe; Gordon J Freeman
Journal:  Semin Immunol       Date:  2021-05-15       Impact factor: 11.130

6.  Introducing a new ESMO Open article series: how I treat side effects of immunotherapy.

Authors:  Matthias Preusser
Journal:  ESMO Open       Date:  2019-07-05

7.  Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity.

Authors:  Changping Zhou; Lu Ma; Han Xu; Yingqing Huo; Jincai Luo
Journal:  Cell Res       Date:  2022-03-17       Impact factor: 46.297

8.  Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.

Authors:  Friedrich Erhart; Matthias Hackl; Hannes Hahne; Johanna Buchroithner; Chen Meng; Simone Klingenbrunner; René Reitermaier; Katrin Fischhuber; Susanna Skalicky; Walter Berger; Sabine Spiegl-Kreinecker; Daniela Lötsch; Gerda Ricken; Bernhard Kuster; Adelheid Wöhrer; Georg Widhalm; Johannes Hainfellner; Thomas Felzmann; Alexander M Dohnal; Christine Marosi; Carmen Visus
Journal:  NPJ Vaccines       Date:  2020-01-16       Impact factor: 7.344
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.